The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNEL.L Regulatory News (CNEL)

  • There is currently no data for CNEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

26 Jun 2015 07:00

RNS Number : 3192R
China New Energy Ltd
26 June 2015
 

26 June 2015

 

China New Energy Limited

("CNE" or "the Company")

 

Final Results for the Year Ended 31 December 2014

 

The Board of CNE (AIM:CNEL), the AIM quoted engineering and technology solutions provider to the bioenergy sector, presents its final results for the year ended 31 December 2014.

 

 

Highlights:

 

· Total revenue of RMB57 million (c.£6.0 million) an increase of 29.5% from RMB44 million (c. £4.6 million)

 

· Acquired 24% of the issued equity of the Visontai Bioetanol Fejlesztő Korlátolt Felelősségű Társaság ("Visontai") bioethanol project in Hungary for €250,000.

 

· MOU with Ubon Bio Ethanol Co., Ltd ("Ubon") to build a second biorefinery in Thailand

 

· Winner of the China Alcoholic Drinks Association's ("CADA") 2013 annual award for Science and Technology Improvement in recognition of the Company's patented Five-Tower Two-stage Differential Pressure Distillation Equipment & Process for Superfine-grade Edible Alcohol technology (Patent Number ZL 2007 1 0030550.8).

 

· Total order book currently stands at RMB533 million (c. £55.8 million)

 

Indicative exchange rates as at 31 December 2014 £1: RMB 9.56

Source : www.oanda.com

 

 

 

Mr. Yu commented "Our strategy of focusing on emerging markets including Eastern Europe, South East Asia and Africa is beginning to gain traction and I am very pleased that the order book is now RMB533 million (c. £55.8 million). I am especially pleased with our 24% equity stake in the Visontai ethanol project, because when it enters production, it will help us achieve our goal of generating recurring income".

 

 

For further information, please visit www.chinanewenergy.co.uk or contact:

 

China New Energy Limited

www.chinanewenergy.co.uk

Richard Bennett

rbennett@zkty.com.cn Tel: +44 7966 388374

Ivy Xu

xuhj@zkty.com.cn Tel: +86 20 8705 9371

 

 

Cairn Financial Advisers LLP (Nomad)

Tel: +44 20 7148 7900

Jo Turner / Liam Murray

 

 

 

Daniel Stewart and Co

Tel: +44 20 7776 6550

Martin Lampshire / David Coffman

_________

 

 

CHAIRMAN'S STATEMENT

 

 

For the year ended 31 December 2014, the group's total revenue was RMB57 million (c. £6.0 million), an increase of 29.5% from RMB44 million (c. £4.6 million).

 

We are pleased to see signs of a recovery within the global ethanol market. Over the last few years the industry has faced many headwinds due to the global economy and, not least, due to the recent fall in oil prices. The management team of China New Energy Ltd ("the Company" or "CNE") has responded to this by focussing on emerging markets that benefit most from ethanol production including South East Asia, Eastern Europe and Africa. I am very pleased that this strategy is beginning to gain traction and that the group, being CNE and its subsidiary, secured new contracts in 2014 of RMB84.8 million (c. £8.9 million) and our total order book balance is now RMB533 million (c. £55.8 million).

 

The gross profit for the year was RMB4.3 million (c. £0.45 million) up from gross loss of RMB2.3 million (c. £0.24 million), which is in line with the increased revenue. Through cost cutting measures, the selling and administrative expenses decreased by 5.7% from RMB15.6 million (c. £1.6 million) to RMB14.7 million (c £1.54 million). The net overprovision of bad debts in the previous year of RMB7 million (c. £0.73 million) is reversed compared to impairment of RMB33.8 million (c. £3.53 million) in 2013.

 

For the year 2014, the company recorded a net loss for the year of RMB8.5 million (c. £0.89 million), a decrease from a net loss of RMB 59.2 million (c. £6.2 million).

 

Products and Services

 

The group principally provides EPC (Equipment, Procurement and Construction) services and VAS (Value Added Service) to ethanol and biobutanol producers. The EPC team primarily design and build commercial-scale biorefineries that convert feedstock into ethanol for both the biofuel and edible alcohol markets, whilst the VAS team provide services and technology to optimise the ethanol production at existing biorefineries.

 

CNE is a market leader in China at designing and building 1st Generation biorefineries that convert agricultural feedstock such as corn, cassava and sugarcane into ethanol. We have completed more than 100 1st Generation projects in China and around the world.

 

The market is now evolving as our customers in China and other developed nations seek to use cellulosic (non-food) feedstock such as corn stover and municipal waste in 2nd Generation biorefineries. It remains a priority for CNE to commercialise the 2nd Generation technology, as we believe this will stimulate demand for building new biorefineries in China and around the world.

 

Group Strategy and Sales Pipeline

 

The Group's strategy remains to: 

1) Acquire equity interest in biorefinery projects. The board seeks to diversify from EPC contracts where income can be uneven, and develop operating businesses with consistent recurring income.

2) Sell VAS and maintenance services to existing customers. In particular the board sees opportunity to sell energy efficiency technology to reduce the operating costs for current customers.

3) Sell EPC contracts to develop biorefinery projects. The company is focusing on 1st Generation projects in emerging countries in Africa, Eastern Europe and South East Asia and 2nd Generation projects in China and other mature markets.

 

I am pleased to report that CNE is making progress in all 3 areas. Most significantly we are making progress to our goal of delivering consistent recurring income. After the yearend, CNE acquired a 24% stake in the Visontai Bioetanol Fejlesztő Korlátolt Felelősségű Társaság ("Visontai") bioenergy project that we are developing in Hungary. The completed biorefinery is expected to produce 150 million litres of bioethanol per year, which will be sold to the international market. Total gross EPC income from the contract is expected to be €34 million from which c.€11 million will be due to local contractors. Once the biorefinery is commissioned, CNE expects to earn a recurring income from the sales of ethanol in 2017 and beyond.

 

We also continue to make progress on our sales pipeline of EPC contracts, particular in South East Asia and Sub-Saharan Africa. CNE recently completed the design and construction of UBE's cassava-to-ethanol biorefinery in Thailand. Since opening, the project has won many accolades for the positive impact on the local community including: creating 600 jobs at the biorefinery, creating economic opportunities for 10,000 cassava out-growers and reducing the local cost of petrol. As a result of this, UBE has commissioned a second project from CNE. To meet local environmental legislation, UBE is currently conducting an Environmental Impact Assessment ("EIA") for the new project. UBE has reported to CNE that it expects to gain regulatory approval and commence the project in 2015.

 

In Sub-Saharan Africa, CNE entered into a development partnership with Sunbird Bioenergy Africa ("Sunbird") in 2013 with the intention of developing an initial 120 million litre per year cassava-to-ethanol biorefinery in Nigeria with an additional 9 projects forecast across the region. In Nigeria, Sunbird and the local development partner OBAX World Wide Limited ("OBAX") reported that they have completed the land and agricultural survey and crop enumeration of the 20,000 Ha of land for the project and are awaiting the final certificate of occupancy from the Ministry of Agriculture and Rural Development. Sunbird and OBAX have met the conditions needed for the certificate of occupancy and expect it to be granted imminently. It is likely that the project will commence in 2015 and CNE will be responsible for the design and biorefinery technology.

 

During the period, CNE reviewed Sunbird's project pipeline for the region and met with key stakeholders in Zambia and Zimbabwe. As in Thailand, employment and energy security were identified as the key drivers for bioenergy projects in the region. Sunbird has been awarded an investment license by the Zambian Development Agency for US$150 million to build a cassava to ethanol biorefinery and cassava plantation. CNE is optimistic about tendering for a part of this business in due course.

 

Research and development

 

A major goal of CNE remains to commercialise 2nd Generation technology that converts cellulosic biomass (agricultural waste) into fuel grade ethanol and butanol. During the year, our R&D team made significant progress in developing new processes and achieved recognition as a provincial R&D centre from previous city's level. We applied for four new invention patents. The group now holds a total of 29 patents and intends to remain a leading developer of intellectual property in the bioenergy sector.

 

Outlook

 

In general, I am optimistic about the group's prospects in 2015 and beyond. CNE has the strongest order book and sales pipeline that we have had in recent years for our EPC services, and we are making steady progress towards our goal of owning a biorefinery project and delivering a recurring income from the sales of ethanol. There is no doubt that there will be challenges due to the global economic climate and the unstable oil price. However, the Board and management are feeling energized and committed to deliver growth this year, and build a strong foundation for sustainable growth in the future.

 

On behalf of the Board, I would like to extend my appreciation to our valued shareholders, supportive business partners and associates, insightful management and dedicated staff for all their contribution and commitment towards the company. I would also like to thank the Board of Directors for their invaluable counsel in steering the group through this exciting time.

 

 

 

 

CONSOLIDATED AND COMPANY STATEMENT OF FINANCIAL POSITION

AT 31 DECEMBER 2014

 

 

 

Group

As at 31 December

 

Company

As at 31 December

 

 

2014

 

2013

 

2014

 

2013

Restated

 

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

Non-current assets

 

 

 

 

 

 

 

 

Property, plant and equipment

 

7,900

 

11,747

 

-

 

-

Intangible assets

 

8,138

 

6,392

 

-

 

-

Trade receivables

 

3,523

 

3,523

 

-

 

-

Investment in subsidiary

 

-

 

-

 

37,141

 

44,253

Investment

 

-

 

150

 

- 

 

- 

 

 

19,561

 

21,812

 

37,141

 

44,253

Current assets

 

 

 

 

 

 

 

 

Inventories

 

11,841

 

15,698

 

-

 

-

Due from customers for construction contracts

 

 

38,075

 

 

48,516

 

-

 

-

Trade and other receivables

 

45,167

 

43,249

 

3,631

 

3,702

Cash and cash equivalents

 

14,875

 

15,198

 

4,497

 

3,731

 

 

109,958

 

122,661

 

8,128

 

7,433

Current liabilities

 

 

 

 

 

 

 

 

Borrowings

 

6,600

 

6,600

 

-

 

-

Trade and other payables

 

77,452

 

88,693

 

11,063

 

13,153

Due to customers for construction contracts

 

14,040

 

15,414

 

-

 

-

Income tax payable

 

8,776

 

8,776

 

17

 

18

 

 

106,868

 

119,483

 

11,080

 

13,171

 

 

 

 

 

 

 

 

 

Net current assets/(liabilities)

 

3,090

 

3,178

 

(2,952)

 

(5,738)

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

815

 

815

 

-

 

-

 

 

815

 

815

 

-

 

-

 

 

 

 

 

 

 

 

 

Net assets

 

21,836

 

24,175

 

34,189

 

38,515

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

Share capital

 

1,325

 

1,214

 

1,325

 

1,214

Share premium

 

54,925

 

49,118

 

54,925

 

49,118

Combination reserve

 

(33,156)

 

(33,156)

 

-

 

-

Statutory reserve

 

12,328

 

12,328

 

-

 

-

Warrant reserve

 

1,673

 

1,673

 

1,673

 

1,673

Own shares

 

-

 

(5,853)

 

-

 

-

Accumulated losses

 

(38,895)

 

(24,690)

 

(17,182)

 

(8,101)

Foreign currency translation reserve

 

23,636

 

23,541

 

(6,552)

 

(5,389)

 

 

21,836

 

24,175

 

34,189

 

38,515

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED AND COMPANY STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 31 DECEMBER 2014

 

 

Note

Group

Year ended 31 December

 

Company

Year ended 31 December

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

Restated

 

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

 

 

 

 

Revenue

30

57,309

 

44,367

 

-

 

-

 

 

 

 

 

 

 

 

 

Cost of sales

 

(53,010)

 

(46,705)

 

-

 

-

 

 

 

 

 

 

 

 

 

Gross profit/(loss)

 

4,299

 

(2,338)

 

-

 

-

Other operating income

20

323

 

1,147

 

-

 

-

Selling and distribution expenses

 

(3,200)

 

(3,626)

 

-

 

-

Administrative expenses

 

(11,517)

 

(11,987)

 

(3,332)

 

(2,969)

Other operating expenses

21

(1,857)

 

(1,695)

 

-

 

-

Finance costs

 

(791)

 

(995)

 

(8)

 

(655)

Bad debts provision (net)

 

6,970

 

(33,772)

 

-

 

-

Impairment loss on investment

 

(150)

 

(30,800)

 

-

 

(16,738)

Impairment loss on PPE

 

(1,500)

 

-

 

-

 

-

Impairment on inventories

 

(1,031)

 

-

 

-

 

-

Other gains and losses

19

-

 

24,866

 

(5,741)

 

24,866

 

 

 

 

 

 

 

 

 

(Loss)/profit before tax

22

(8,454)

 

(59,200)

 

(9,081)

 

4,504

Income tax expense

23

(10)

 

7

 

-

 

-

(Loss)/profit for the year attributable to owners of the company

 

(8,464)

 

(59,193)

 

(9,081)

 

4,504

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

 

Items that may be reclassified subsequently to profit or loss

 

 

 

 

 

 

 

 

Exchange difference arising on translating foreign operations

 

95

 

1,196

 

(1,163)

 

(37)

Exchange difference on cancellation of EBT

 

112

 

-

 

-

 

-

Other comprehensive income for the year

 

207

 

1,196

 

(1,163)

 

(37)

 

 

 

 

 

 

 

 

 

Total comprehensive income for the year attributable to owners of the company

 

(8,257)

 

(57,997)

 

(10,244)

 

4,467

 

 

 

 

 

 

 

 

 

Loss per share (RMB)

24

 

 

 

 

 

 

 

Basic

 

(0.023)

 

 (0.185)

 

 

 

 

Diluted

 

(0.023)

 

(0.190)

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share (Pence)

 

 

 

 

 

 

Basic

 

 

(0.242)

 

 (1.847)

 

Diluted

 

 

(0.242)

 

(1.894)

 

 

Exchange rate £1: RMB9.6841 (2013: £1: RMB10.0056)

 

 

CONSOLIDATED AND COMPANY STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2014

 

 

 

Group

As at 31 December

Company

As at 31 December

 

 

 

2014

2013

2014

2013

 

 

 

RMB'000

RMB'000

RMB'000

RMB'000

 

Operating activities

 

 

 

 

 

 

(Loss)/profit before tax

 

(8,454)

(59,200)

(9,081)

4,504

 

Adjustments for:

 

 

 

 

 

 

Depreciation and amortisation

 

2,619

2,219

-

-

 

Bad debt provision (net)

 

(6,970)

33,772

-

-

 

Loss/(gain) on disposal of PPE

 

2

(223)

-

-

 

Redemption of Citadel bond

 

-

(24,866)

-

(24,866)

 

Interest income

 

(92)

(153)

 -

 -

 

Interest expenses

 

791

995

-

655

 

Impairment of inventories

 

1,031

-

-

-

 

Impairment of PPE

 

1,500

-

-

-

 

Impairment of investment

 

150

30,800

-

16,738

 

Cancellation of EBT

 

-

-

5,477

-

 

Exchange difference

 

207

-

472

-

 

Operating cash flows before movements in working capital

 

(9,216)

(16,656)

(3,132)

(2,969)

 

Decrease/(increase) in inventories

 

2,826

(3,412)

-

-

 

Decrease in due from customers for construction contract

 

10,283

24,219

-

-

 

(Increase)/decrease in trade and other receivables

 

(9,125)

(4,895)

71

113

 

Increase/(decrease) in trade and other payables

 

2,529

(6,521)

(2,091)

(1,628)

 

(Decrease)/increase in due to customers for construction contract

 

(809)

4,889

-

-

 

Cash used in operations

 

(3,512)

(2,376)

(5,152)

(4,484)

 

Income taxes paid

 

(10)

(246)

-

-

 

Net cash used in operating activities

 

(3,522)

(2,622)

(5,152)

(4,484)

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Purchase of property, plant and equipment

 

(71)

(2,956)

-

-

 

Expenditure on intangible assets

 

(1,949)

(1,831)

-

-

 

Net cash used in investing activities

 

(2,020)

(4,787)

-

-

 
 

Financing activities

 

 

 

 

 

 

Proceeds from borrowings

 

6,600

6,600

-

-

 

Repayment of borrowings

 

(6,600)

-

-

-

 

Proceeds from issuance of shares

 

5,918

10,027

5,918

10,027

 

Redemption of convertible bonds

 

-

(4,488)

-

(4,488)

 

Dividend received

 

-

-

-

2,634

 

Interest received

 

92

153

-

-

 

Interest paid

 

(791)

(995)

-

(3)

 

Net cash from financing activities

 

5,219

11,297

5,918

8,170

 

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

(323)

3,888

766

3,686

 

Cash and cash equivalents at beginning of year

 

15,198

11,310

3,731

45

 

Effect of exchange rate changes

 

-

-

-

-

 

Cash and cash equivalents at end of year

 

14,875

15,198

4,497

3,731

 

 

 

 

 

 

 

 
         

 

 

Notes to the financial statements

 

1. General information

The company (or "CNE") with registration number 93306 was incorporated in Jersey on 2 May 2006 as an investment holding company. The company is domiciled in Jersey with its registered office at Queensway House, Hilgrove Street, St Helier, Jersey JE1 1ES.

 

The principal activities of its main subsidiary, Guangdong Zhongke Tianyuan New Energy Science and Technology Co Ltd. ("ZKTY") are engaged in turnkey technology solutions to manufacturers of ethanol, edible alcohol and acetic acid from a range of bio-resources including corn, sugarcane, cassava and other bio-resources.

The principal place of business is located at No 4, Nengyuan Road, Wushan, Tianhe District, Guangzhou, People's Republic of China ("PRC").

 

2. Basis of preparation

 

The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the EU ("IFRS") issued by the International Accounting Standards Board ("IASB"), including related Interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC").

 

The consolidated financial statements incorporate the financial information of the company and its subsidiaries ("the group"). The subsidiaries are entities (including special purposes entities) over which the company has the power to govern the financial operating policies, generally accompanied by a shareholding giving rise to the majority of the voting rights, as to obtain benefits from their activities.

 

The individual financial statements of each group entity are measured and presented in the currency of the primary economic environment in which the entity operates (its functional currency). The consolidated financial statements of the group are presented in Chinese Renminbi ("RMB"), which is the presentation currency for the consolidated and company financial statements. The functional currency of the company is British pound sterling ("GBP"). As the group mainly operates in the PRC, RMB is used as the presentation currency of the group. All financial information presented in RMB has been recorded to the nearest thousand.

 

The group has adopted all relevant standards effective for accounting periods beginning on or after 1 January 2014.

 

As at end of the reporting year, the group has not adopted the following standard as it is either not effective or not applicable to the group's business.

 

3. Loss per share

 

The calculation of loss per share is based on group's loss for the year and the weighted average number of shares in issue after adjusting for movement in own shares during the financial year. There is no potential dilutive share or share options outstanding and therefore, the diluted loss per share is the same as basic loss per share.

 

Loss

 

Weighted average number of shares

 

Loss per share

 

RMB'000

 

'000

 

RMB

2014

 

 

 

 

 

Basic

(14,205)

 

361,318

 

(0.039 )

Diluted

(14,205)

 

361,318

 

(0.039)

 

 

 

 

 

 

2013

 

 

 

 

 

Basic

(59,193)

 

320,314

 

(0.185 )

Diluted

(59,193)

 

312,234

 

(0.190)

 

 

4. Notice of AGM and Posting of Accounts

The annual general meeting ("AGM") will be held at 8th Floor, Technology Integration Building of GIEC, No. 4 Nengyuan Road, Wushan, Tianhe District, Guangzhou, China, on 24 July 2015 at 16:00 Beijing time (09:00 London time).

 

The full version of the report and accounts for the year ended 31 December 2014 is available from the Company's website www.chinanewenergy.co.uk and notification of posting of the accounts, together with the Notice of AGM, will shortly be sent to all shareholders.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SEUSIMFISEEM
Date   Source Headline
14th Jul 20206:00 pmRNSChina New Energy
14th Jul 20204:49 pmRNSHKEx Admission and Cancellation of Trading on AIM
14th Jul 20202:05 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:06 amRNSSecond Price Monitoring Extn
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSGlobal Offering, Issue of Equity and HKEx update
30th Jun 20207:00 amRNSPublication of Prospectus and Global Offering
29th Jun 20204:40 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSHong Kong Listing Update
8th Jun 202011:05 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:08 pmRNSConvertible Loan Extension
16th Apr 202010:31 amRNSResult of AGM
30th Mar 202011:56 amRNSResubmission of Hong Kong Listing Application
26th Mar 20201:53 pmRNSPosting of Circular and Notice of AGM
26th Mar 202012:56 pmRNSFinal Results
11th Feb 20207:00 amRNSTrading Update and Coronavirus Information
4th Feb 20202:05 pmRNSSecond Price Monitoring Extn
4th Feb 20202:00 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSHong Kong Listing Update
24th Oct 20198:36 amRNSDirector/PDMR Shareholding
23rd Oct 201910:35 amRNSResult of EGM
15th Oct 20192:05 pmRNSSecond Price Monitoring Extn
15th Oct 20192:00 pmRNSPrice Monitoring Extension
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:28 pmRNSPosting of Circular and Notice of EGM
27th Sep 20193:45 pmRNSHalf-year Report
5th Sep 20192:05 pmRNSSecond Price Monitoring Extn
5th Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 20194:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20194:36 pmRNSPrice Monitoring Extension
29th Jul 201910:13 amRNSResult of AGM
26th Jul 20192:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20194:11 pmRNSHolding(s) in Company
23rd Jul 20193:31 pmRNSHolding(s) in Company
22nd Jul 201911:20 amRNSDirector/PDMR Shareholding
28th Jun 20198:31 amRNSNotice of AGM
25th Jun 20197:00 amRNSUpdate re Listing
19th Jun 20195:59 pmRNSFinal Results
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
15th Mar 20197:00 amRNSDirector's Dealing
21st Feb 20197:00 amRNSAppointment of Broker
8th Feb 20199:05 amRNSSecond Price Monitoring Extn
8th Feb 20199:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSConvertible Loan Agreement
17th Dec 20184:39 pmRNSTrading Update
24th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.